ArticleOpen forum infectious diseases2023

Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients With Coronavirus Disease 2019 (COVID-19) Using Nationwide Real-World Data: An Observational Matched Cohort Study From the Japan COVID-19 Task Force.

Hiromu Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.